Movement Alert|Semtech Rises 5.01% in Regular Trading, Institutional Target Prices and Product Line Expansion Fuel Rebound

Market Focus
5 hours ago

On October 1, Semtech rose 5.01% in regular trading, trading at 187.72 USD/share, with Turnover of $323 million. The rally extends a recovery from a recent pullback triggered by concentrated insider selling, as institutional support and product catalysts continue to underpin bullish sentiment.

On the institutional front, Seaport initiated coverage with a Buy rating and a $200 price target, while UBS raised its target to $230. The consensus analyst target stands at approximately $209, implying meaningful upside from recent lows. The sustained endorsement from multiple brokerages has attracted buying interest on pullbacks, helping the stock regain ground lost during the prior selloff to the $172 level.

On the product side, Semtech recently announced the mass production of LR2022 and LR2012 transceivers under its flagship LoRa Plus chip family, completing a three-chip production matrix covering Sub-GHz, satellite-direct, and edge-AI IoT deployment scenarios. Additionally, the company signed a definitive agreement to divest its cellular module business to Compal Electronics for $62 million in cash, signaling a strategic refocus on higher-growth core segments.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10